Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'Hartmann, JT' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 65 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Hartmann, JT; Einhorn, L; Nichols, CR; Droz, JP; Horwich, A; Gerl, A; Fossa, SD; Beyer, J; Pont, J; Schmoll, HJ; Kanz, L; Bokemeyer, C
      Second-line chemotherapy in patients with relapsed extragonadal nonseminomatous germ cell tumors: Results of an international multicenter analysis

      JOURNAL OF CLINICAL ONCOLOGY
    2. Fizazi, K; Tjulandin, S; Salvioni, R; Germa-Lluch, JR; Bouzy, J; Ragan, D; Bokemeyer, C; Gerl, A; Flechon, A; de Bono, JS; Stenning, S; Horwich, A; Pont, J; Albers, P; De Giorgi, U; Bower, M; Bulanov, A; Pizzocaro, G; Aparicio, J; Nichols, CR; Theodore, C; Hartmann, JT; Schmoll, HJ; Kaye, SB; Culine, S; Droz, JP; Mahe, C
      Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: Prognostic factors and role of postsurgery chemotherapy-results from an international study group

      JOURNAL OF CLINICAL ONCOLOGY
    3. Rick, O; Bokemeyer, C; Beyer, J; Hartmann, JT; Schwella, N; Kingreen, D; Neureither, S; Metzner, B; Casper, J; Wandt, H; Hartmann, F; Schmoll, HJ; Derigs, G; Gerl, A; Berdel, WE; Kanz, L; Siegert, W
      Salvage treatment with paclitaxel, ifosfamide, and cisplatin plus high-dose carboplatin, etoposide, and thiotepa followed by autologous stem-cell rescue in patients with relapsed or refractory germ cell cancer

      JOURNAL OF CLINICAL ONCOLOGY
    4. Bokemeyer, C; Droz, JP; Horwich, A; Gerl, A; Fossa, SD; Beyer, J; Pont, J; Schmoll, HJ; Kanz, L; Einhorn, L; Nichols, CR; Hartmann, JT
      Extragonadal seminoma - An international multicenter analysis of prognostic factors and long term treatment outcome

      CANCER
    5. Hartmann, JT; von Vangerow, A; Fels, LM; Knop, S; Stolte, H; Kanz, L; Bokemeyer, C
      A randomized trial of amifostine in patients with high-dose VIC chemotherapy plus autologous blood stem cell transplanation

      BRITISH JOURNAL OF CANCER
    6. Hartmann, JT; Fossa, SD; Nichols, CR; Droz, JP; Horwich, A; Gerl, A; Beyer, J; Pont, J; Fizazi, K; Hecker, H; Kanz, L; Einhorn, L; Bokemeyer, C
      Incidence of metachronous testicular cancer in patients with extragonadal germ cell tumors

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    7. Hartmann, JT; Knop, S; Fels, LM; van Vangerow, A; Stolte, H; Kanz, L; Bokemeyer, C
      The use of reduced doses of amifostine to ameliorate nephrotoxicity of cisplatin/ifosfamide-based chemotherapy in patients with solid tumors

      ANTI-CANCER DRUGS
    8. Kollmannsberger, C; Nichols, C; Bamberg, M; Hartmann, JT; Schleucher, N; Beyer, J; Schoffski, P; Derigs, G; Ruther, U; Bohlke, I; Schmoll, HJ; Kanz, L; Bokemeyer, C
      First-line high-dose chemotherapy +/- radiation therapy in patients with metastatic germ-cell cancer and brain metastases

      ANNALS OF ONCOLOGY
    9. Bokemeyer, C; Kollmannsberger, C; Hartmann, JT; Kanz, L
      Follow up after primary treatment: curable diseases treated non-surgically

      ANNALS OF ONCOLOGY
    10. Bokemeyer, C; Hartmann, JT; Mayer, F; Bohlke, I; Kanz, L; von Pawel, J; Derigs, G; Schroder, M
      UFT/leucovorin plus weekly paclitaxel in the treatment of solid tumors

      ONCOLOGY-NEW YORK
    11. Hartmann, JT; Fels, LM; Franzke, A; Knop, S; Renn, M; Maess, B; Panagiotou, P; Lampe, H; Kanz, L; Stolte, H; Bokemeyer, C
      Comparative study of the acute nephrotoxicity from standard dose cisplatin+/- ifosfamide and high-dose chemotherapy with carboplatin and ifosfamide

      ANTICANCER RESEARCH
    12. Hartmann, JT; Kanz, L; Bokemeyer, C
      Phase II study of continuous 120-hour- infusion of mitomycin C as salvage chemotherapy in patients with progressive or rapidly recurrent gastrointestinal adenocarcinoma

      ANTICANCER RESEARCH
    13. Hartmann, JT; Fels, LM; Knop, S; Stolte, H; Kanz, L; Bokemeyer, C
      A randomized trial comparing the nephrotoxicity of cisplatin/ifosfamide-based combination chemotherapy with or without amifostine in patients with solid tumors

      INVESTIGATIONAL NEW DRUGS
    14. Hartmann, JT; Bokemeyer, C
      Diarrhea and constipation

      SUPPORTIVE CARE IN CANCER PATIENTS: RECENT DEVELOPMENTS
    15. Hartmann, JT; Nichols, CR; Droz, JP; Horwich, A; Gerl, A; Fossa, SD; Beyer, J; Pont, J; Einhorn, L; Kanz, L; Bokemeyer, C
      The relative risk of second nongerminal malignancies in patients with extragonadal germ cell tumors

      CANCER
    16. Kollmannsberger, C; Quietzsch, D; Haag, C; Lingenfelser, T; Schroeder, M; Hartmann, JT; Baronius, W; Hempel, V; Clemens, M; Kanz, L; Bokemeyer, C
      A phase II study of paclitaxel, weekly, 24-hour continuous infusion 5-fluorouracil, folinic acid and cisplatin in patients with advanced gastric cancer

      BRITISH JOURNAL OF CANCER
    17. Hartmann, JT; Nichols, CR; Droz, JP; Horwich, A; Gerl, A; Fossa, SD; Beyer, J; Pont, J; Fizazi, K; Einhorn, L; Kanz, L; Bokemeyer, C
      Hematologic disorders associated with primary mediastinal nonseminomatous germ cell tumors

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    18. Kollmannsberger, C; Kuzcyk, M; Mayer, F; Hartmann, JT; Kanz, L; Bokemeyer, C
      Late toxicity following curative treatment of testicular cancer

      SEMINARS IN SURGICAL ONCOLOGY
    19. Hartmann, JT; Quietzsch, D; Daikeler, T; Kollmannsberger, C; Mayer, F; Kanz, L; Bokemeyer, C
      Mitomycin C continuous infusion as salvage chemotherapy in pretreated patients with advanced gastric cancer

      ANTI-CANCER DRUGS
    20. Kollmannsberger, C; Brugger, W; Hartmann, JT; Maurer, F; Bohm, P; Kanz, L; Bokemeyer, C
      Phase II study of oral trofosfamide as palliative therapy in pretreated patients with metastatic soft-tissue sarcoma

      ANTI-CANCER DRUGS
    21. Bokemeyer, C; Hartmann, JT; Kollmannsberger, C; Mayer, F; Kanz, L
      UFT/calcium folinate plus weekly paclitaxel for solid tumors

      ONCOLOGY-NEW YORK
    22. Bokemeyer, C; Kollmannsberger, C; Meisner, C; Harstrick, A; Beyer, J; Metzner, B; Hartmann, JT; Schmoll, HL; Einhorn, L; Kanz, L; Nichols, C
      First-line high-dose chemotherapy compared with standard-dose PEB/VIP chemotherapy in patients with advanced germ cell tumors: A multivariate and matched-pair analysis

      JOURNAL OF CLINICAL ONCOLOGY
    23. Hartmann, JT; Kuczyk, MA; Kollmannsberger, C; Kanz, L; Bokemeyer, C
      Future prospects in the chemotherapy of metastatic nonseminomatous testicular germ-cell cancer

      WORLD JOURNAL OF UROLOGY
    24. Hartmann, JT; Bokemeyer, C
      Chemotherapy for renal cell carcinoma

      ANTICANCER RESEARCH
    25. Bokemeyer, C; Kollmannsberger, C; Harstrick, A; Beyer, J; Gerl, A; Casper, J; Metzner, B; Hartmann, JT; Schmoll, HJ; Kanz, L
      Treatment of patients with cisplatin-refractory testicular germ-cell cancer

      INTERNATIONAL JOURNAL OF CANCER
    26. Kollmannsberger, C; Hartmann, JT; Kanz, L; Bokemeyer, C
      Therapy-related malignancies following treatment of germ cell cancer

      INTERNATIONAL JOURNAL OF CANCER
    27. Hartmann, JT; Kollmannsberger, C; Kanz, L; Bokemeyer, C
      Platinum organ toxicity and possible prevention in patients with testicular cancer

      INTERNATIONAL JOURNAL OF CANCER
    28. Hartmann, JT; Kanz, L; Bokemeyer, C
      Diagnosis and treatment of patients with testicular germ cell cancer

      DRUGS
    29. Hartmann, JT; Albrecht, C; Schmoll, HJ; Kuczyk, MA; Kollmannsberger, C; Bokemeyer, C
      Long-term effects on sexual function and fertility after treatment of testicular cancer

      BRITISH JOURNAL OF CANCER
    30. Bokemeyer, C; Hartmann, JT
      Oral and gastrointestinal toxicity

      ANTICANCER DRUG TOXICITY
    31. HARTMANN JT; SCHMOLL E; BOKEMEYER C; FETY R; LUCAS C; GIROUX B; SCHMOLL HJ
      PHASE-I PHARMACOLOGICAL STUDY OF INTRAARTERIALLY INFUSED FOTEMUSTINE FOR COLORECTAL LIVER METASTASES

      European journal of cancer
    32. HARTMANN JT; HARSTRICK A; DAIKELER T; KOLLMANNSBERGER C; MULLER C; SEEBER S; KANZ L; BOKEMEYER C
      PHASE-II STUDY OF CONTINUOUS 120 H INFUSION OF MITOMYCIN-C AS SALVAGECHEMOTHERAPY IN PATIENTS WITH PROGRESSIVE OR RAPIDLY RECURRENT COLORECTAL-CANCER

      Anti-cancer drugs
    33. KOLLMANNSBERGER C; QUIETZCH D; CLEMENS M; LAMPE C; LINGENFELSER T; HARTMANN JT; KANZ L; BOKEMEYER C
      A PHASE-II TRIAL OF PACLITAXEL, CISPLATIN, AND WEEKLY 24 H INFUSION OF 5-FLUOROURACIL (5-FU) FOLINIC ACID (FA) IN PATIENTS (PTS) WITH ADVANCED GASTRIC-CANCER/

      Annals of oncology
    34. BOKEMEYER G; KOLLMANNSBERGER O; SOKLER W; DOHMEN BM; OECHSLE K; HARTMANN JT; PFANNENBERG AC; BARES R; KANZ L
      FDG-PET FOR THE EVALUATION OF HIGH-DOSE CHEMOTHERAPY (HD-CTX) IN PATIENTS WITH METASTATIC GERM-CELL TUMORS (GCT)

      Annals of oncology
    35. HARTMANN JT; NICHOLS CR; DROZ JP; HORWICH A; GERL A; FOSSA SD; BEYER J; PONT J; SCHMOLL HJ; BOKEMEYER C
      EXTRAGONADAL GERM-CELL TUMORS (EGGCT) AND HEMATOLOGIC DISORDERS - INCIDENCE AND OUTCOME FROM AN INTERNATIONAL DATABASE

      Annals of oncology
    36. KOLLMANNSBERGER C; BOYER J; DROZ JP; HARSTRICK A; HARTMANN JT; BIRON P; FLECHON A; SCHOFFSKI P; KUCZYK M; SCHMOLL HJ; KANZ L; BOKEMEYER C
      SECONDARY LEUKEMIA FOLLOWING HIGH CUMULATIVE DOSES OF ETOPOSIDE IN PATIENTS TREATED FOR ADVANCED GERM-CELL TUMORS

      Journal of clinical oncology
    37. BOKEMEYER C; HARTMANN JT; KUCZYK MA; TRUSS MC; KOLLMANNSBERGER C; BEYER J; JONAS U; KANZ L
      RECENT STRATEGIES FOR THE USE OF PACLITAXEL IN THE TREATMENT OF UROLOGICAL MALIGNANCIES

      World journal of urology
    38. HARTMANN JT; ALBERS P; CLEMM C; SOUCHON R; WEISSBACH L; BAMBERG M; BOKEMEYER C
      REGISTER STUDY FOR THE TREATMENT OF BRAIN METASTASES OF MALIGNANT TESTICULAR-TUMORS

      Onkologie
    39. BOKEMEYER C; HARSTRICK A; BEYER J; METZNER B; RUTHER U; HARTMANN JT; HOLSTEIN K; DERIGS HG; DEWIT R; CASPER J; SCHOFFSKI P; KUHRER I; ILLIGER HJ; KEMPF B; REICHLE A; FOLLER A; HOSSFELD DK; FISCHER JT; BERDEL W; GERHARTZ H; KIRCHNER H; PFLUGER K; OSTERMANN H; KANZ L; SCHMOLL HJ
      FIRST-LINE HIGH-DOSE CHEMOTHERAPY FOR POOR-RISK METASTATIC NONSEMINOMATOUS TESTICULAR GERM-CELL TUMORS

      Onkologie
    40. KUCZYK MA; KOHN G; HOFNER K; MACHTENS S; BOKEMEYER C; STIEF CG; TRUSS MC; SCHAFERS HJ; HARTMANN JT; JONAS U
      PROGNOSTIC VALUE OF INTRACAVAL NEOPLASTIC EXTENSION FOR PATIENTS WITHRENAL-CELL CANCER

      Der Urologe
    41. HARTMANN JT; ALBERS P; CLEMM C; SOUCHON R; WEISSBACH L; BAMBERG M; BOKEMEYER C
      REGISTER STUDY OF PATIENTS WITH CNS METASTASES FROM TESTICULAR GERM-CELL CANCER

      Strahlentherapie und Onkologie
    42. KOLLMANNSBERGER C; HARTMANN JT; KANZ L; BOKEMEYER C
      RISK OF SECONDARY MYELOID-LEUKEMIA AND MYELODYSPLASTIC SYNDROME FOLLOWING STANDARD-DOSE CHEMOTHERAPY OR HIGH-DOSE CHEMOTHERAPY WITH STEM-CELL SUPPORT IN PATIENTS WITH POTENTIALLY CURABLE MALIGNANCIES

      Journal of cancer research and clinical oncology
    43. BOKEMEYER C; HARSTRICK A; BEYER J; METZNER B; RUTHER U; HARTMANN JT; HOLSTEIN K; DERIGS HG; DEWIT R; CASPER J; SCHOFFSKI P; KUHRER I; ILLIGER HJ; KEMPF B; REICHLE A; FOLLER A; HOSSFELD DK; FISCHER JT; BERDEL WE; GERHARTZ HH; KIRCHNER H; PFLUGER KH; OSTERMANN H; KANZ L; SCHMOLL HJ
      THE USE OF DOSE-INTENSIFIED CHEMOTHERAPY IN THE TREATMENT OF METASTATIC NONSEMINOMATOUS TESTICULAR GERM-CELL TUMORS

      Seminars in oncology
    44. HARTMANN JT; KOHNE CH; SCHMOLL HJ; DAIKELER T; KANZ L; BOKEMEYER C
      IS CONTINUOUS 24-HOUR INFUSION OF 5-FLUOROURACIL PLUS HIGH-DOSE FOLINIC ACID EFFECTIVE IN PATIENTS WITH PROGRESSIVE OR RECURRENT COLORECTAL-CANCER - A PHASE-II STUDY

      Oncology
    45. BOKEMEYER C; BERGER CC; HARTMANN JT; KOLLMANNSBERGER C; SCHMOLL HJ; KUCZYK MA; KANZ L
      ANALYSIS OF RISK-FACTORS FOR CISPLATIN-INDUCED OTOTOXICITY IN PATIENTS WITH TESTICULAR CANCER

      British Journal of Cancer
    46. Bokemeyer, C; Harstrick, A; Beyer, J; Metzner, B; Ruther, U; Hartmann, JT; Holstein, K; Derig, HG; De Wit, R; Casper, J; Schoffski, P; Kuhrer, I; Illiger, HJ; Kempf, B; Reichle, A; Foller, A; Hossfeld, DK; Fischer, JT; Berdel, WE; Gerhartz, HH; Kirchner, H; Pfluger, KH; Ostermann, H; Kanz, L; Schmoll, HJ
      The use of intensive chemotherapy for non-seminomatous testicular germ cell tumors

      EUROCANCER 98
    47. DAIKELER T; MAAS K; WEISS B; HARTMANN JT; KNOBLOCH A; ARNING M; KANZ L; BOKEMEYER C
      THE INFLUENCE OF GEMCITABINE ON THE CD4 CD8 RATIO IN PATIENTS WITH SOLID TUMORS/

      Oncology Reports
    48. HARTMANN JT; SCHMOLL E; BOKEMEYER C; FETY R; LUCAS C; DAGAY L; SCHMOLL HJ
      HEPATIC ARTERIAL INFUSION OF THE NITROSOUREA DERIVATE FOTEMUSTINE FORTHE TREATMENT OF LIVER METASTASES FROM COLORECTAL-CARCINOMA

      Oncology Reports
    49. HARTMANN JT; CANDELARIA M; KUCZYK MA; SCHMOLL HJ; BOKEMEYER C
      COMPARISON OF HISTOLOGICAL RESULTS FROM THE RESECTION OF RESIDUAL MASSES AT DIFFERENT SITES AFTER CHEMOTHERAPY FOR METASTATIC NONSEMINOMATOUS GERM-CELL TUMORS

      European journal of cancer
    50. BOKEMEYER C; HARTMANN JT; FELS L; KNOP S; STOLTE H; KANZ L
      AMIFOSTINE PROTECTS AGAINST ACUTE CISPLATIN IFOSFAMIDE-INDUCED KIDNEYDAMAGE ASSESSED BY MEASUREMENT OF GLOMERULAR AND TUBULAR ENZYMES/

      European journal of cancer
    51. HARTMANN JT; ALBRECHT C; KANZ L; BOKEMEYER C
      LONG-TERM EFFECTS OF TESTICULAR CANCER-TREATMENT ON SEXUAL FUNCTIONING

      European journal of cancer
    52. HARTMANN JT; KOHNE CH; SCHMOLL HJ; KOLLMANNSBERGER C; KANZ L; BOKEMEYER C
      PHASE-II STUDY OF 24 HOURS-INFUSION OF 5-FLUOROURACIL AND HIGH-DOSE FOLINIC ACID IN PATIENTS WITH PROGRESSIVE OR RECURRENT COLORECTAL-CANCER (CRC)

      European journal of cancer
    53. HARTMANN JT; CANDELARIA M; JACKH G; SCHMOLL HJ; HARSTRICK A; KANZ L; BOKEMEYER C
      CONTINUOUS 120 HOURS-INFUSION OF MITOMYCIN-C (MMC) AS SALVAGE TREATMENT IN PROGRESSIVE OR RAPIDLY RECURRENT GASTRIC-CANCER

      European journal of cancer
    54. DAIKELER T; MAAS K; HARTMANN JT; KANZ L; BOKEMEYER C
      WEEKLY SHORT INFUSIONS OF GEMCITABINE ARE NOT ASSOCIATED WITH SUPPRESSION OF LYMPHATIC ACTIVITY IN PATIENTS WITH SOLID TUMORS

      Anti-cancer drugs
    55. BOKEMEYER C; LAMPE CS; CLEMENS MR; HARTMANN JT; QUIETZSCH D; FORKMANN L; KOLLMANNSBERGER C; KANZ L
      A PHASE-II TRIAL OF PACLITAXEL AND WEEKLY 24 H INFUSION OF 5-FLUOROURACIL FOLINIC ACID IN PATIENTS WITH ADVANCED GASTRIC-CANCER

      Anti-cancer drugs
    56. HARTMANN JT; SCHMOLL HJ; KUCZYK MA; CANDELARIA M; BOKEMEYER C
      POSTCHEMOTHERAPY RESECTIONS OF RESIDUAL MASSES FROM METASTATIC NONSEMINOMATOUS TESTICULAR GERM-CELL TUMORS

      Annals of oncology
    57. BOKEMEYER C; NOWAK P; HAUPT A; METZNER B; KOHNE H; HARTMANN JT; KANZ L; SCHMOLL HJ
      TREATMENT OF BRAIN METASTASES IN PATIENTS WITH TESTICULAR CANCER

      Journal of clinical oncology
    58. HARTMANN JT; SCHMOLL HJ; THIEL I; KANZ L; BOKEMEYER C
      TREATMENT OF PATIENTS WITH MALIGNANT FIBR OUS HISTOCYTOMA OF THE BONEAND REVIEW OF CHEMOTHERAPY RESULTS

      Tumordiagnostik & Therapie
    59. BOKEMEYER C; HARTMANN JT; LAMPE CS; CLEMENS MR; QUIETZSCH D; FORKMANN L; KANZ L
      PACLITAXEL AND WEEKLY 24-HOUR INFUSION OF 5-FLUOROURACIL FOLINIC ACIDIN ADVANCED GASTRIC-CANCER

      Seminars in oncology
    60. BOKEMEYER C; FRANZKE A; HARTMANN JT; SCHOBER C; ARSENIEV L; METZNER B; LINK H; KANZ L; SCHMOLL HJ
      A PHASE I II STUDY OF SEQUENTIAL, DOSE-ESCALATED, HIGH-DOSE IFOSFAMIDE PLUS DOXORUBICIN WITH PERIPHERAL-BLOOD STEM-CELL SUPPORT FOR THE TREATMENT OF PATIENTS WITH ADVANCED SOFT-TISSUE SARCOMAS/

      Cancer
    61. HARTMANN JT; THIEL I; SCHMOLL HJ; EINSELE H; KANZ L; BOKEMEYER C
      MALIGNANT FIBROUS HISTIOCYTOMA OF BONE - REVIEW OF 13 CASES

      Oncology Reports
    62. BOKEMEYER C; HARTMANN JT; KUCZYK MA; TRUSS MC; BEYER J; JONAS U; KANZ L
      THE ROLE OF PACLITAXEL IN CHEMOSENSITIVE UROLOGICAL MALIGNANCIES - CURRENT STRATEGIES IN BLADDER-CANCER AND TESTICULAR GERM-CELL TUMORS

      World journal of urology
    63. BOKEMEYER C; KUCZYK MA; SERTH J; HARTMANN JT; SCHMOLL HJ; JONAS U; KANZ L
      TREATMENT OF CLINICAL STAGE-I TESTICULAR CANCER AND A POSSIBLE ROLE FOR NEW BIOLOGICAL PROGNOSTIC PARAMETERS

      Journal of cancer research and clinical oncology
    64. BOKEMEYER C; NOWAK P; METZNER B; HAUPT A; HARTMANN JT; SCHMOLL HJ
      EXTRAGONADAL GERM-CELL TUMORS (EGGCT) - EXPERIENCE AT HANNOVER-UNIVERSITY MEDICAL-SCHOOL

      European journal of cancer
    65. BOKEMEYER C; BELDER B; HECKER H; KUCZYK MA; HARTMANN JT; SCHMOLL HJ
      THE ROLE OF SERUM ESTROGENE LEVELS FOR PATIENTS WITH TESTICULAR CANCER

      European journal of cancer


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 27/11/20 alle ore 13:19:46